Lutetium Long-term Safety Follow-up study
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
April 1, 2023
End Date
September 30, 2035
Administered By
Duke Cancer Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
April 1, 2023
End Date
September 30, 2035